Lv3
400 积分 2024-06-11 加入
Crosstalk between oncogenic MYC and noncoding RNAs in cancer
2个月前
已完结
An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network
4个月前
已完结
An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network
4个月前
已完结
An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network
4个月前
已完结
Non-coding RNAs in disease: from mechanisms to therapeutics
4个月前
已完结
Current paradigms in epigenetic anticancer therapeutics and future challenges
4个月前
已完结
Drug discovery for epigenetics targets
4个月前
已完结
Lung cancer treatment: 20 years of progress
4个月前
已完结
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
4个月前
已完结
High-throughput characterization of functional variants highlights heterogeneity and polygenicity underlying lung cancer susceptibility
4个月前
已完结
皖公网安备34019202002308
